Cargando…
Long-term results of a study using individualized planning target volumes for hypofractionated intensity-modulated radiotherapy boost for prostate cancer
BACKGROUND: This is the final report of a prospective phase I study which evaluated the feasibility, toxicities, and biochemical control in prostate cancer patients treated with a hypofractionated boost utilizing a fiducial marker-based daily image guidance strategy and small patient-specific PTV ma...
Autores principales: | Chu, William, Loblaw, D Andrew, Chan, Kelvin, Morton, Gerard, Choo, Richard, Szumacher, Ewa, Danjoux, Cyril, Pignol, Jean-Philippe, Cheung, Patrick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4407385/ https://www.ncbi.nlm.nih.gov/pubmed/25903934 http://dx.doi.org/10.1186/s13014-015-0400-1 |
Ejemplares similares
-
Evolution of Hypofractionated Accelerated Radiotherapy for Prostate Cancer – The Sunnybrook Experience
por: Musunuru, Hima Bindu, et al.
Publicado: (2014) -
Prostatic displacement during extreme hypofractionated radiotherapy using volumetric modulated arc therapy (VMAT)
por: Gladwish, Adam, et al.
Publicado: (2014) -
Clinical evaluation of an endorectal immobilization system for use in prostate hypofractionated Stereotactic Ablative Body Radiotherapy (SABR)
por: Nicolae, Alexandru, et al.
Publicado: (2015) -
Hypofractionated Proton Boost Combined with External Beam Radiotherapy for Treatment of Localized Prostate Cancer
por: Johansson, Silvia, et al.
Publicado: (2012) -
Outcomes of hypofractionated stereotactic body radiotherapy boost for intermediate and high-risk prostate cancer
por: Anwar, Mekhail, et al.
Publicado: (2016)